Navigation Links
Investigational agent targets gene signaling pathways to improve response for patients with CLL
Date:12/8/2012

ls and communications pathways in cancer, we are improving our ability to effectively treat the disease while avoiding the toxicities of chemotherapy and potential relapse," said John C. Byrd, MD, lead author and Director of the Division of Hematology at The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute in Columbus. "If we can replicate these high survival rates and good tolerability with ibrutinib through larger scale Phase III studies, we may find it to be an extremely valuable new therapy for not just elderly, but for all CLL patients."

Dr. Byrd will present this study in an oral presentation on Sunday, December 9, at 5:00 p.m. EST at the Georgia World Congress Center in Thomas Murphy Ballroom 4, Level 5, Building B.

The BTK Inhibitor Ibrutinib (PCI-32765) in Combination with Rituximab is Well−Tolerated and Displays Profound Activity in High-Risk Chronic Lymphocytic Leukemia (CLL) Patients [Abstract 187]

The combination of the novel investigational agent ibrutinib with an established therapeutic antibody, rituximab, may present a safer and more effective option than the current standard chemotherapy-based treatment regimen for patients with high-risk CLL.

While current chemotherapy-based treatment options for CLL patients are effective, they come with toxic side effects that are challenging for elderly patients. Physicians have long awaited new options that offer better tolerability. Ibrutinib is designed to selectively target leukemia cell growth, with the aim of effectively treating the disease without the toxicities of chemotherapy. Data from earlier studies of ibrutinib have shown it to be equally effective in both low- and high-risk CLL.

High-risk CLL patients typically have unfavorable responses to standard CLL therapies and a dismal outcome. S
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
2. Rilpivirine for HIV: Added benefit for single agent proven
3. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
4. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
5. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
6. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
7. New substances 15,000 times more effective in destroying chemical warfare agents
8. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
9. Imaging agents predict breast cancer response to endocrine therapy
10. Pig stomach mucins are effective as anti-viral agents for consumer products
11. Method developed by VTT targets diagnosis of early Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... person we all seem to know who we say is ... she isn,t unable to act but simply doesn,t want to., ... A study of nearly 4,000 college students in 19 countries ... making decisions and moving forward with life. Turns out that ... they just don,t like it as much as non-neurotics. Therefore ...
(Date:4/22/2014)... is available in German . ... of the University of Vienna and the Medical University of ... shown how double stranded RNA, such as viral genetic information, ... the immune response against viral infection, the protein ADAR1 moves ... modifies viral RNA to inhibit reproduction of the virus. But ...
(Date:4/22/2014)... their total brain size suggests they have more ... according to a new study of 36 species ... zebra finches. , Scientists at Duke University, UC ... research institutions collaborated on this first large-scale investigation ... study as the ability to inhibit powerful but ...
(Date:4/22/2014)... familiar trope in science fiction: In enemy territory, activate ... to make themselves invisible to the immune system. Now ... have mimicked these viral tactics to build the first ... , The results pave the way for smart DNA ... and more accurately than doctors can today; target drugs ...
(Date:4/22/2014)... researchers have found that the anxiety experienced with ... negatively impact a woman,s overall well-being. Their findings ... which was published online in the April 21, ... from 40 to 60 percent of women who ... will experience a false-positive mammogram. Such mammograms require ...
Breaking Medicine News(10 mins):Health News:Neurotics don't just avoid action: They dislike it 2Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3Health News:Brain size matters when it comes to animal self-control 2Health News:Brain size matters when it comes to animal self-control 3Health News:Cloaked DNA nanodevices survive pilot mission 2Health News:Cloaked DNA nanodevices survive pilot mission 3Health News:False-positive mammogram anxiety has limited impact on women's well-being 2
... Nutrition Inc. Chooses ,it, Girl PR to help promote their ... ... "it" Girl Public relations, one of,the leading Public Relations ... of Optimal Nutrition Inc. (O.N.I.).,O.N.I. bestows a customized door-to-door organic ...
... Group, a life sciences,focused, corporate, investor and public ... as agency of record by Agile Therapeutics, of,Princeton, ... Donna LaVoie, President and CEO, commented, "LaVoie ... tactical execution to these,exciting companies as they accelerate ...
... Expand Agency ... Representation in Massachusetts -, WORCESTER, Mass., Nov. 19 ... writer of auto, home and,business insurance in Massachusetts, announced today ... enhanced auto product that will,deliver highly- competitive prices and innovative ...
... Wealth Measures: Three-Quarters Say Governments, Should Look Beyond ... BRUSSELS, Belgium, Nov. 19 Three-quarters of,people in ... and include health, social and environmental statistics in,measuring ... growth,alone is the most important measure. Around ...
... CorVel Corporation,(Nasdaq: CRVL ) today announced ... stock under the stock repurchase program previously approved,by ... the Board had approved a,1,500,000 share expansion to ... has repurchased 862,323 shares, with a remaining 637,677,shares ...
... ThalesNano Inc.,and the Christian Doppler Laboratory ... Graz today announced a scientific,collaboration on flow/microwave ... application of flow reactors for organic synthesis ... background in,continuous processing. ThalesNano and the Christian ...
Cached Medicine News:Health News:'it' Girl Public Relations Adds 'O.N.I.' New Organic Food Delivery Service to Its Lifestyle Division 2Health News:LaVoie Group Adds Two New Companies to Its Life Science Client Roster 2Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 2Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 3Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 4Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 2Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 3Health News:CorVel Corporation Announces Resumption of Stock Repurchases 2Health News:CorVel Corporation Announces Resumption of Stock Repurchases 3Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 2Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 3
(Date:1/15/2014)... Medical is very pleased to announce the appointment of Mr. ... Officer.  Mark was promoted from his current role of Chief ... facilities in Massachusetts , Mississippi ... in 2012 with 20+ years of broad-based operations, sales, engineering ...
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... 2010 UK based Trimega Laboratories is pleased to announce ... set by the prestigious Investors in People (IIP) Standard. ... Representative Quality Board of IIP and reflects the commitment and ... significant aspect of the achievement is that, as a ...
... and SYDNEY, Nov. 11, 2010 HeartWare International, Inc. ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that CEO Doug Godshall is scheduled to make ... Annual Healthcare Conference on Wednesday, November 17, at 1:15 ...
Cached Medicine Technology:IIP Recognition for Substance Abuse Testing Lab Trimega Laboratories 2HeartWare to Present at the Lazard Capital Markets 7th Annual Healthcare Conference 2
... Single Use Loading Units With ... ILA™ 75 (Single Use Reloadable ... ,INDICATIONS The ILA™ 75 single-use ... for use in the resection, ...
... The Auto Suture™ GIA™ Reloadable Staplers ... application in abdominal, gynecological, pediatric and ... and creation of anastomosis. , ... and the SGIA™ Knifeless Stapler have ...
... Staplers are anastomotic staplers available in four ... to lumen diameter. The staplers permit tissue ... improve access and ease of use. The ... compression by adjusting the height of the ...
... ENDOPATH STEALTH Intraluminal Staplers are anastomotic ... proper matching of instrument to lumen diameter. ... detachable anvil head to improve access and ... surgeon to control tissue compression by adjusting ...
Medicine Products: